Hwail Pharmaceutical Co.,Ltd. (KOSDAQ: 061250)

Hwail Pharmaceutical Co.,Ltd. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Cash & Equivalents	9,399	8,304	4,664	4,266	8,260	8,469
Short-Term Investments	2,432	1,743	1,986	4,951	1,947	1,050
Cash & Short-Term Investments	11,831	10,048	6,650	9,217	10,207	9,519
Cash Growth	12.32%	51.10%	-27.86%	-9.70%	7.23%	28.89%
Accounts Receivable	39,870	39,264	41,933	38,055	31,517	37,927
Other Receivables	1,762	1,710	258.31	222.18	550.98	388.68
Receivables	41,736	41,078	42,295	38,381	34,767	40,932
Inventory	23,438	24,803	31,933	25,942	26,931	24,227
Prepaid Expenses	12.37	20.2	33.1	31.04	26.48	41.11
Other Current Assets	65.11	174.97	107.28	490.49	771.92	1,277
Total Current Assets	77,082	76,124	81,017	74,062	72,703	75,997
Property, Plant & Equipment	35,241	35,688	37,654	39,040	38,907	29,835
Long-Term Investments	7,772	8,775	12,958	1,178	3,232	2,170
Other Intangible Assets	4,031	4,171	4,835	4,813	4,190	648.67
Long-Term Accounts Receivable	3.1	8.1	3.1	-	104.55	-
Long-Term Deferred Charges	-	-	-	-	3.99	23.69
Other Long-Term Assets	3,833	3,850	3,803	3,832	3,884	4,237
Total Assets	127,963	128,616	140,272	122,924	123,024	113,139
Accounts Payable	4,957	5,755	6,476	6,777	5,105	7,791
Accrued Expenses	777.16	744.46	930.46	1,071	5,117	324.64
Short-Term Debt	9,085	8,012	18,379	11,873	10,572	14,466
Current Portion of Long-Term Debt	1,355	1,355	3,355	1,355	1,355	358.32
Current Income Taxes Payable	1,748	2,515	1,550	289.35	657.08	884.74
Current Unearned Revenue	237.02	264.03	35.45	121.15	34.28	119.38
Other Current Liabilities	2,814	523.27	2,765	375.86	2,552	412.59
Total Current Liabilities	20,974	19,169	33,491	21,862	25,392	24,356
Long-Term Debt	5,387	5,726	5,081	8,435	9,790	2,920
Long-Term Deferred Tax Liabilities	11.15	326.49	2,757	1,179	1,530	1,763
Other Long-Term Liabilities	3,560	3,534	-	2,378	-	1,877
Total Liabilities	29,933	28,755	41,328	33,854	36,715	30,916
Common Stock	7,205	7,205	7,205	7,205	7,205	7,010
Additional Paid-In Capital	21,675	21,675	21,675	21,675	21,675	20,671
Retained Earnings	74,009	75,152	70,799	66,698	63,919	61,023
Treasury Stock	-6,478	-6,478	-6,478	-6,478	-6,478	-6,478
Comprensive Income & Other	1,617	2,305	5,741	-31.6	-13.11	-2.65
Shareholders' Equity	98,030	99,861	98,944	89,070	86,309	82,223
Total Liabilities & Equity	127,963	128,616	140,272	122,924	123,024	113,139
Total Debt	15,827	15,093	26,815	21,663	21,717	17,744
Net Cash (Debt)	-3,997	-5,045	-20,165	-12,446	-11,510	-8,225
Net Cash Per Share	-98.52	-124.36	-496.76	-307.26	-283.46	-205.89
Filing Date Shares Outstanding	40.57	40.57	40.57	40.57	40.57	39.4
Total Common Shares Outstanding	40.57	40.57	40.57	40.57	40.57	39.4
Working Capital	56,108	56,955	47,527	52,200	47,311	51,640
Book Value Per Share	2416.39	2461.52	2438.92	2195.54	2127.48	2087.06
Tangible Book Value	93,999	95,690	94,109	84,257	82,120	81,575
Tangible Book Value Per Share	2317.02	2358.71	2319.73	2076.90	2024.21	2070.59
Land	9,311	9,311	9,311	9,311	9,311	9,099
Buildings	19,577	19,720	20,291	20,861	20,564	10,640
Machinery	6,272	6,647	8,023	8,811	3,607	3,649
Construction In Progress	81.3	10.5	30.45	57	5,426	6,448

Source: S&P Capital IQ. Standard template. Financial Sources.